Elizabeth Goodwin

Biochemistry, Genetics and Molecular Biology · Life Sciences

9h-index415citations17works1.52yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Muscle Physiology and Disorders(9), Cardiomyopathy and Myosin Studies(3), Biochemical and Molecular Research(3), Mitochondrial Function and Pathology(2), Genetic Neurodegenerative Diseases(2)

Publications17 total

Sex Differences in the Genetic Causes of Dilated Cardiomyopathy
Journal of the American College of Cardiology·2025· 3 citedOpen Access
Supplementary tables: Ataluren delays loss of ambulation and respiratory decline in nonsense mutation Duchenne muscular dystrophy patients
Figshare·2024Open Access
Comparison of pharmaceutical properties and biological activities of prednisolone, deflazacort, and vamorolone in DMD disease models
Human Molecular Genetics·2023· 16 citedOpen Access
Aromatic L-amino acid decarboxylase deficiency: a systematic review
Future Neurology·2022· 11 citedOpen Access
Emvododstat, a Potent Dihydroorotate Dehydrogenase Inhibitor, Is Effective in Preclinical Models of Acute Myeloid Leukemia
Frontiers in Oncology·2022· 13 citedOpen Access
Ataluren delays loss of ambulation and respiratory decline in nonsense mutation Duchenne muscular dystrophy patients
Journal of Comparative Effectiveness Research·2021· 58 citedOpen Access
Unesbulin – a Novel Anti-tubulin Cancer Therapeutic
Journal of Clinical Haematology·2021Open Access
Ataluren Delays Loss of Ambulation and Decline in Pulmonary Function in Patients with Nonsense Mutation Duchenne Muscular Dystrophy (2553)
Neurology·2021· 1 cited
Pharmacokinetics and Safety of PTC596, a Novel Tubulin‐Binding Agent, in Subjects With Advanced Solid Tumors
Clinical Pharmacology in Drug Development·2021· 21 cited
The DHODH inhibitor PTC299 arrests SARS-CoV-2 replication and suppresses induction of inflammatory cytokines
Virus Research·2020· 70 citedOpen Access
Metabolite V, an epoxide species is a minor circulating metabolite in humans following a single oral dose of deflazacort
Pharmacology Research & Perspectives·2020· 3 citedOpen Access
DMD – THERAPY
Neuromuscular Disorders·2020
The DHODH Inhibitor PTC299 Arrests SARS-CoV-2 Replication and Suppresses Induction of Inflammatory Cytokines
2020· 7 citedOpen Access
In vitro metabolism, reaction phenotyping, enzyme kinetics, CYP inhibition and induction potential of ataluren
Pharmacology Research & Perspectives·2020· 13 citedOpen Access
Metabolism and Disposition of Ataluren after Oral Administration to Mice, Rats, Dogs, and Humans
Drug Metabolism and Disposition·2020· 9 citedOpen Access
Adverse Event Profile of Pyrimethamine-Based Therapy in Toxoplasmosis: A Systematic Review
Drugs in R&D·2017· 167 citedOpen Access
Toxoplasmic encephalitis relapse rates with pyrimethamine-based therapy: systematic review and meta-analysis
Pathogens and Global Health·2017· 23 citedOpen Access

Frequent Co-authors

Ronald Kong(8), Marla Weetall(7), Joseph M. Colacino(6), Kylie O’Keefe(5), Francesco Bibbiani(5), M. Tulinius(5), Ellen Welch(4), Francesco Muntoni(4), Vinay Penematsa(4), Joel Jiang(4), Allan Kristensen(4), Heather Gordish‐Dressman(4), Panayiota Trifillis(4), Jason D. Graci(3), Liangxian Cao(3), Christopher R. Trotta(3), Craig M. McDonald(3), Lauren P. Morgenroth(3), Richard Able(3), Jiyuan Ma(3)